Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer
Sponsor: University Health Network, Toronto
Summary
This is a multi-institution, randomized, non-inferiority Phase II trial comparing external beam radiotherapy delivered as 54 Gy in 20 fractions to prostate bed +/- 44 Gy in 20 fractions to pelvic lymph nodes delivered daily with external beam radiotherapy delivered as 30 Gy in 5 fractions to prostate bed +/- 25 Gy in 5 fractions to pelvic lymph nodes delivered on alternate days.
Official title: A Phase II Randomized Trial: ALTERNATE DAY ULTRAHYPOFRACTIONATED OR DAILY MODERATELY HYPOFRACTIONATED POST OPERATIVE RADIOTHERAPY
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
204
Start Date
2024-11-26
Completion Date
2030-11
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
Radiotherapy
Non-institutional-standard radiotherapy
Locations (2)
London Health Sciences Centre
London, Ontario, Canada
University Health Network - Princess Margaret Cancer Centre
Toronto, Ontario, Canada